187 related articles for article (PubMed ID: 25827817)
21. Diagnostic value of (18)F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA.
Gade M; Kubik M; Fisker RV; Thorlacius-Ussing O; Petersen LJ
Cancer Imaging; 2015 Aug; 15(1):11. PubMed ID: 26263901
[TBL] [Abstract][Full Text] [Related]
22. First alert for recurrence during follow-up after potentially curative resection for colorectal carcinoma: CA 19-9 should be included in surveillance programs.
Kawamura YJ; Tokumitsu A; Mizokami K; Sasaki J; Tsujinaka S; Konishi F
Clin Colorectal Cancer; 2010 Jan; 9(1):48-51. PubMed ID: 20100688
[TBL] [Abstract][Full Text] [Related]
23. Intensified follow-up in colorectal cancer patients using frequent Carcino-Embryonic Antigen (CEA) measurements and CEA-triggered imaging: Results of the randomized "CEAwatch" trial.
Verberne CJ; Zhan Z; van den Heuvel E; Grossmann I; Doornbos PM; Havenga K; Manusama E; Klaase J; van der Mijle HC; Lamme B; Bosscha K; Baas P; van Ooijen B; Nieuwenhuijzen G; Marinelli A; van der Zaag E; Wasowicz D; de Bock GH; Wiggers T
Eur J Surg Oncol; 2015 Sep; 41(9):1188-96. PubMed ID: 26184850
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for metachronous adenoma in the residual colon of patients undergoing curative surgery for colorectal cancer.
Patel A; Williams N; Parsons N; Ali O; Peters F; Ranat R; Shah J; Spector E; Arasaradnam RP
Int J Colorectal Dis; 2017 Nov; 32(11):1609-1616. PubMed ID: 28828520
[TBL] [Abstract][Full Text] [Related]
25. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.
Baker JJ; Meyers MO; Frank J; Amos KD; Stitzenberg KB; Ollila DW
Am J Surg; 2014 Apr; 207(4):549-54. PubMed ID: 24674829
[TBL] [Abstract][Full Text] [Related]
26. Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified?
Yamamoto S; Akasu T; Fujita S; Moriya Y
Hepatogastroenterology; 2005; 52(62):444-9. PubMed ID: 15816454
[TBL] [Abstract][Full Text] [Related]
27. Radioimmunoguided surgery in recurrent colorectal cancer: the role of carcinoembryonic antigen, computerized tomography, and physical examination.
Sardi A; Agnone CM; Nieroda CA; Mojzisik C; Hinkle G; Ferrara P; Farrar WB; Bolton J; Thurston MO; Martin EW
South Med J; 1989 Oct; 82(10):1235-44. PubMed ID: 2799440
[TBL] [Abstract][Full Text] [Related]
28. Fifth-year surveillance computed tomography scanning after potentially curative resections for colorectal cancer.
Walter CJ; Al-Allak A; Borley N; Goodman A; Wheeler JM
Surgeon; 2013 Feb; 11(1):25-9. PubMed ID: 22738949
[TBL] [Abstract][Full Text] [Related]
29. Results of long-term follow-up after curative resection of Dukes A colorectal cancer.
Wichmann MW; Müller C; Hornung HM; Lau-Werner U; Schildberg FW;
World J Surg; 2002 Jun; 26(6):732-6. PubMed ID: 12053228
[TBL] [Abstract][Full Text] [Related]
30. The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels.
Sanli Y; Kuyumcu S; Ozkan ZG; Kilic L; Balik E; Turkmen C; Has D; Isik G; Asoglu O; Kapran Y; Adalet I
Ann Nucl Med; 2012 Aug; 26(7):551-8. PubMed ID: 22644560
[TBL] [Abstract][Full Text] [Related]
31. Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.
Reddy JP; Tang C; Shih T; Kim B; Kim C; Nguyen QN; Welsh J; Benveniste M; Zhang J; Liao Z; Gomez DR
Clin Lung Cancer; 2017 Mar; 18(2):141-148. PubMed ID: 27913215
[TBL] [Abstract][Full Text] [Related]
32. Impact of a dedicated cancer center surveillance program on guideline adherence for patients with stage II and III colorectal cancer.
Standeven L; Price Hiller J; Mulder K; Zhu G; Ghosh S; Spratlin JL
Clin Colorectal Cancer; 2013 Jun; 12(2):103-12. PubMed ID: 23153862
[TBL] [Abstract][Full Text] [Related]
33. Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer-Specific Mortality in Patients With Stage II or III Colorectal Cancer: The COLOFOL Randomized Clinical Trial.
Wille-Jørgensen P; Syk I; Smedh K; Laurberg S; Nielsen DT; Petersen SH; Renehan AG; Horváth-Puhó E; Påhlman L; Sørensen HT;
JAMA; 2018 May; 319(20):2095-2103. PubMed ID: 29800179
[TBL] [Abstract][Full Text] [Related]
34. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial.
Rodríguez-Moranta F; Saló J; Arcusa A; Boadas J; Piñol V; Bessa X; Batiste-Alentorn E; Lacy AM; Delgado S; Maurel J; Piqué JM; Castells A
J Clin Oncol; 2006 Jan; 24(3):386-93. PubMed ID: 16365182
[TBL] [Abstract][Full Text] [Related]
35. The clinical utility of the combination of T stage and venous invasion to predict survival in patients undergoing surgery for colorectal cancer.
Roxburgh CS; McMillan DC; Richards CH; Atwan M; Anderson JH; Harvey T; Horgan PG; Foulis AK
Ann Surg; 2014 Jun; 259(6):1156-65. PubMed ID: 24100338
[TBL] [Abstract][Full Text] [Related]
36. 18F-FDG PET/CT superior to serum CEA in detection of colorectal cancer and its recurrence.
Makis W; Kurzencwyg D; Hickeson M
Clin Imaging; 2013; 37(6):1094-7. PubMed ID: 23993799
[TBL] [Abstract][Full Text] [Related]
37. Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations.
Kyoto Y; Momose M; Kondo C; Itabashi M; Kameoka S; Kusakabe K
Ann Nucl Med; 2010 Jun; 24(5):395-401. PubMed ID: 20364373
[TBL] [Abstract][Full Text] [Related]
38. Elevated tumor-to-liver uptake ratio (TLR) from
Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
[TBL] [Abstract][Full Text] [Related]
39. Can (18)F-FDG PET/CT scan change treatment planning and be prognostic in recurrent colorectal carcinoma? A prospective and follow-up study.
Artiko V; Odalovic S; Sobic-Saranovic D; Petrovic M; Stojiljkovic M; Petrovic N; Kozarevic N; Grozdic-Milojevic I; Obradovic V
Hell J Nucl Med; 2015; 18(1):35-41. PubMed ID: 25840571
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]